Deep Dive: Biotech

Biotech Reversal

Downside Projections

Nuremberg 2.0

For what seems the longest time, a recurring focus of this site has been the biotech sector.

Specifically, the IBB (ETF) and SPBIO (Index).

There’s good reason for that. In this update, we’ll go deeper into the downside opportunity.

Biotech Reversal:

SPBIO, topped out on February 9th this year. The IBB (ETF) topped one day later.

Both went on to form a Quarterly reversal bar; indicating a long term change in character.

Of the two, SPBIO has showed more weakness having posted monthly lower lows for three successive months.

That relative weakness over the IBB index, has resulted in focusing on the inverse of SPBIO; specifically the 3X inverse, LABD.

Working with leveraged inverse funds is only profitable on a short-term basis or when the underlying index is in a persistent down-trend.

Otherwise, typical market chop results in value erosion of the inverse fund (not advice, not a recommendation).

For the reasons discussed in the last section below (Nuremburg 2.0), we’re anticipating the index to have a sustained and persistent drop to much lower levels.

Downside Projections:

Going way back to Reminiscences of a Stock Operator and the Wyckoff Stock Market Institute training materials, both in their own way indicated a speculative position was only entered if there was sufficient potential.

Livermore’s 10-points or more and Wyckoff’s cause and effect

In Wyckoff’s case, the ’cause’ was price action congestion built up in the P&F chart.

The ‘effect’ was the resulting move.

Which brings us to now:

Many times on this site, we’ve said biotech has built up congestion in a way, when it reverses and begins its decline, price action itself will create lower targets.

We’ll present two charts showing how that’s happening.

The first P&F chart in this update and provided below, has a projected downside target for IBB around, 116 – 120 area:

Note, the downside is not to scale as the real location is far below the noted area.

Biotech IBB, then went on to post lower action. That in turn has resulted in an updated downside target:

Once again, the downside is not to scale.

It’s apparent, as IBB heads lower, it successively builds lower targets and it’s only (potentially) just getting started.

The weekly chart of IBB below, spells it out:

If and when IBB price action gets to the initial targets, it enters a congestion area that will (by that time) be over seven years wide.

If the trend is still down, that congestion in turn would target even lower levels.

The “-80%” interestingly enough, comes from a quote by Steven Van Metre at this link.

That 80% drop also corresponds to a downside Fibonacci (not shown) projection of 423.6%, on the above chart.

Nuremberg 2.0

This phrase has become so ubiquitous you can do a search for it.

So far, not a single mainstream financial site or YouTuber (still on that platform) has mentioned this fact in their analysis.

The speck injections are mass genocide and intended as such.

Two recent events resulting from injections are here and here.

If all of a sudden, injected pilots can’t fly (the first link), how are goods going to be transported?

Not generally known to the public, commercial air-transport is also used to haul freight (while carrying passengers).

Exactly how all of this (world crime) will break is unknown.

If and when it does, the result in the biotech sector as well as equities in general, could be successive air-pockets all the way down.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Random Notes

There has been so much research over the past week; there’s no time to format it into a concise report.

Here are the links with a brief summary.

Number 1.

South Africa Cash In Transit (CIT) failed heist blows up internet.

Link to short video, Here.

Longer version, Here.

The oligarchs will use the bravery of the driver and shotgun rider as an excuse for ‘cashless society’. Just wait.

Number 2.

Biotech index SPBIO down for the week in five time-frames:

Daily, Weekly, Monthly, Quarterly and Yearly price all posted new lows.

This index is heading down.

Number 3.

There’s no helicopter flying around on Mars.

With atmosphere just 1% of Earth …. give me a break.

From an engineer who worked 24-years in avionics and aircraft flight test and certification, anyone with two photons rubbing together could call out this farce.

Not sure the purpose for the lie … just that it’s a lie.

As a wild engineering guess:

To have such an ‘aircraft’ operate on Mars, the rotor blades would need to be a half-mile long, fifteen feet in width and be weightless themselves; spinning at 600 – 1000 PRM, to be able to lift a 4-lb payload.

Let’s see if anyone has the cajones to do the real math on this one.

Number 4.

Current parallels to The Great Depression can not be refuted.

Benign (25% unemployment) history book accounts are lies.

No surprise there.

One excellent source for what’s likely to happen next; Neil McCoy-Ward and his latest update.

Some comments from the linked livestream posted below:

This is a typical excuse (it’s not 1931) or complaint from those who do not have the neural plasticity to take yesterday’s data and adapt it to the current scenario.

These types of people are not likely to survive

Yes, the medical community (with few exceptions) has been bought.

Good luck facing the judgement. Here’s a link that might get the point home.

Yes indeed, time’s up.

If you’re not awake by now, you’ve had plenty of time … maybe even going back to 1963 or farther still; all wars are bankers wars.

Indeed, gold and silver won’t matter in what’s to come next.

Summary:

There is no guarantee that I and my firm are playing this chess game of collapse correctly.

However, being focused on Bitcoin or Dogecoin as Jerimiah Babe puts it, is buying into the (beast) system. It’s conditioning those involved to accept a digital currency.

At this point, we’re focused on shorting biotech until price action dictates otherwise. Not advice, not a recommendation.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

Depression Diaries

12:26 p.m., EST

The Great Depression is about to be eclipsed by ‘The Greater Depression’.

The Great Depression Diaries, is an excellent glimpse into the realities and timeline of a financial collapse.

Part 1

Part 2

Part 3

After watching and listening to all segments, if you changed the dates, you’d think it’s talking about the here and now.

Three key takeaways are:

  1. Intentional destruction of the food supply
  2. Real unemployment numbers falsified
  3. People starved to death

We can look at today’s payroll data as a pivot point. For whatever reason (out of work, being paid not to work), the economy’s not coming back.

The belief the economy’s going to be stronger once the benefits run out (as stated in the linked article) is false.

The current economy is being intentionally destroyed.

That’s not too hard to determine.

Here’s just one more bit of data (unverified, but still of note) to support that assessment.

If you’re unemployed, starving to death, you’ll be a ready face-diaper wearing compliant subject; easily coerced into being injected (executed).

Obviously, the goal is to be as independent, self-employed as possible so we’re not that person.

Which brings us to the culprit du jour: Biotech.

Yesterday, the expectation was for a reversal and test (that day) before SPBIO continued its downward trajectory (LABD higher).

It looks like the test is lasting two days (maybe more) instead of one.

Inverse fund, LABD is currently trading near 24.15. That’s right in the vicinity of the expected range between 23.90 – 24.30, stated yesterday.

LABD did push a little bit lower in the early session to 23.68, but still within expected range.

LABD is testing the right side channel line and trying its best to break through. Thus far, the low for the day remains at 23.68.

If there’s an upward (LABD) reversal from here, a Fibonacci Day 8, from the original Day 55 low, it would give more confirmation we’re at least following the trendline; potentially at the very right side of a huge trading range.

Stay Tuned

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.